FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic

AstraZeneca PLC (NASDAQ:AZN) Q1 2024 Earnings Call Transcript

J&J, Bristol Myers latest to lose bids to halt Medicare price negotiations

AstraZeneca Admits Its COVID-19 Vaccine May Cause Blood Clotting Side Effect In Very Rare Case, But Causal Mechanism Unknown

AstraZeneca’s Fasenra: Approval for asthma may initiate COPD approval

AstraZeneca Says Enhertu Phase 3 Trial Shows 'Statistically Significant' Progression-Free Breast Cancer Survival Improvement

UK Stocks: AstraZeneca (AZN) Shares Rise on Promising Breast Cancer Drug Updates

AstraZeneca, Daiichi look to broaden Enhertu use again with new study data

ENHERTU® (fam-trastuzumab deruxtecan-nxki) improved PFS in HER2-low and ultralow

AstraZeneca PLC (LON:AZN) Beat Earnings, And Analysts Have Been Reviewing Their Forecasts

Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates

Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates

Fusion (FUSN) to Report Q1 Earnings: Here's What to Expect

Fusion (FUSN) to Report Q1 Earnings: Here's What to Expect

Top 4 Health Care Stocks That May Plunge This Month

AstraZeneca CEO on US-China tensions: 'We have established a very resilient supply chain'

AstraZeneca (AZN) Q1 Earnings & Sales Beat Estimates, Stock Up

AstraZeneca (AZN) Q1 Earnings & Sales Beat Estimates, Stock Up

AstraZeneca Plc (AZN) Q1 2024 Earnings Call Transcript

Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales